"authorisation"

Says final decision with government, all norms followed in vaccine approval

The approval to Covaxin has been questioned by industry experts and some opposition Congress leaders who have expressed concern over the absence of phase 3 trial data

Company intends to invest Rs 8,000 crore over the next five years across India